AI-powered diagnostic tools for women's health conditions. Our first product aims to dramatically reduce the current diagnosis time for endometriosis by automatically analysing existing ultrasound scans for the subtle signs of the condition. Endometriosis takes an average of 8 years to diagnose, leaving millions of women undiagnosed or misdiagnosed and leading to very long waiting lists. Today’s gold-standard diagnostic tool is costly, invasive, and resource-intensive surgery. Our technologies help patients communicate symptoms clearly, and automates analysis of the ultrasound scans currently taken for suspected endometriosis. This enables faster, more accurate triaging at primary care and significantly reduces costs across the entire diagnostic pathway.
| Website | https://www.revela.health |
| Employees | 6 (2 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
Looking for a particular Revela employee's phone or email?
Molly Jowsey is the CEO and Co-founder of Revela.
2 people are employed at Revela.